Post-genome-wide association study dissects genetic vulnerability and risk gene expression of Sjögren’s disease for cardiovascular disease
Top Cited Papers
Open Access
- 11 May 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-18
Abstract
This study aims to clarify the genetic associations between Sjögren’s Disease (SD) and cardiovascular disease (CVD) outcomes, and to conduct an in-depth exploration of specific pleiotropic susceptibility genes. We performed two-sample and multivariable Mendelian randomization (MR) analysis to investigate the association between SD and the risk of ischemic heart disease (IHD) and stroke. Linkage disequilibrium score regression (LDSC) and Bayesian co-localization analyses were employed to assess the genetic associations between traits. Cross-phenotype analyses were employed to identify shared variants and genes, followed by a Transcriptome-Wide Association Study (TWAS) and Multi-marker Analysis of Genomic Annotation (MAGMA) based on Multi-Trait Analysis of GWAS (MTAG) results. To validate the pleiotropic genes, we further analyzed tissue-specific differentially expressed genes (DEGs) related to SD using RNA sequencing data. The two-sample and multivariable MR analyses revealed that SD confers a genetic vulnerability to IHD and stroke. LDSC and co-localization analyses indicated a strong genetic linkage between SD and CVDs. Cross-phenotype analyses identified 38 and 37 pleiotropic single nucleotide polymorphisms (SNPs) for SD-Stroke and SD-IHD, respectively, primarily located within the MHC class region on 6p21.32:33 loci. Additionally, TWAS and MAGMA analyses identified pleiotropic genes located outside the MHC regions—seven associated with stroke (UHRF1BP1, SNRPC, BLK, FAM167A, ARHGAP27, C8orf12, and PLEKHM1) and two associated with IHD (UHRF1BP1 and SNRPC). Proxy variants within these genes in SD suggested an increased causal risk for stroke or IHD. Co-localization analysis further reinforced that SD and stroke share significant SNPs within the loci of FAM167A, BLK, C8orf12, SNRPC, and UHRF1BP1. DEG analysis revealed a significant up-regulation of the identified genes in SD-specific tissues. SD appears genetically predisposed to an increased risk of CVDs. Moreover, this research not only identified pleiotropic genes shared between SD and CVDs, but also, for the first time, detected key gene expressions that elevate CVD risk in SD patients—findings that may offer promising therapeutic targets for patient management.Keywords
Funding Information
- Chongqing Science and Health Joint Traditional Chinese Medicine Technology Key Project (2024ZYZD010)
This publication has 85 references indexed in Scilit:
- Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studiesJournal of Neurology, 2022
- Cardiac involvement in primary Sjӧgren’s syndromeRheumatology International, 2021
- Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2018
- Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar CellsInflammation, 2018
- FAM13A and POM121C are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association studyDiabetologia, 2018
- Cross-Phenotype Association Analysis Using Summary Statistics from GWAS2017
- Genome‐Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to AncestryArthritis & Rheumatology, 2017
- Identification of susceptibility gene associated with female primary Sjögren’s syndrome in Han Chinese by genome-wide association studyHuman Genetics, 2016
- Precocious intima‐media thickening in patients with primary Sjögren's syndromeArthritis & Rheumatism, 2005
- Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)Arthritis & Rheumatism, 2004